Abstract
Remdesivir is an antiviral drug, a novel nucleotide analog prodrug. It has been found to be an in-vitro potent inhibitor of RNA viruses including (severe acute respiratory syndrome coronavirus 2) SARS-CoV-2 but its in-vivo potency is still under active investigations. Coronavirus disease 2019 is an infectious disease caused by SARS-CoV-2. In the absence of a proven effective therapy, current management with remdesivir appears to have a favorable clinical safety profile, as reported on the basis of experience, including healthy volunteers and patients treated for acute Ebola virus infection.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
